Correlation Between RYOHIN UNSPADR1 and Moderna

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both RYOHIN UNSPADR1 and Moderna at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RYOHIN UNSPADR1 and Moderna into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RYOHIN UNSPADR1 and Moderna, you can compare the effects of market volatilities on RYOHIN UNSPADR1 and Moderna and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RYOHIN UNSPADR1 with a short position of Moderna. Check out your portfolio center. Please also check ongoing floating volatility patterns of RYOHIN UNSPADR1 and Moderna.

Diversification Opportunities for RYOHIN UNSPADR1 and Moderna

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between RYOHIN and Moderna is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding RYOHIN UNSPADR1 and Moderna in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moderna and RYOHIN UNSPADR1 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RYOHIN UNSPADR1 are associated (or correlated) with Moderna. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moderna has no effect on the direction of RYOHIN UNSPADR1 i.e., RYOHIN UNSPADR1 and Moderna go up and down completely randomly.

Pair Corralation between RYOHIN UNSPADR1 and Moderna

Assuming the 90 days trading horizon RYOHIN UNSPADR1 is expected to generate 0.65 times more return on investment than Moderna. However, RYOHIN UNSPADR1 is 1.55 times less risky than Moderna. It trades about 0.11 of its potential returns per unit of risk. Moderna is currently generating about -0.05 per unit of risk. If you would invest  865.00  in RYOHIN UNSPADR1 on September 19, 2024 and sell it today you would earn a total of  1,275  from holding RYOHIN UNSPADR1 or generate 147.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

RYOHIN UNSPADR1  vs.  Moderna

 Performance 
       Timeline  
RYOHIN UNSPADR1 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in RYOHIN UNSPADR1 are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain forward-looking signals, RYOHIN UNSPADR1 reported solid returns over the last few months and may actually be approaching a breakup point.
Moderna 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Moderna has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

RYOHIN UNSPADR1 and Moderna Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with RYOHIN UNSPADR1 and Moderna

The main advantage of trading using opposite RYOHIN UNSPADR1 and Moderna positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RYOHIN UNSPADR1 position performs unexpectedly, Moderna can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moderna will offset losses from the drop in Moderna's long position.
The idea behind RYOHIN UNSPADR1 and Moderna pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios